INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT

• click to rate

  Posted by Two Blokes Jun 6 - Filed in Stock - 7 views
  
  NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.